Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Rosario

Rosario Cammarota, Irvine, CA US

Patent application numberDescriptionPublished
20120197626Method and System for Predicting Performance of Software Applications on Prospective Hardware Architecture - A system and method for identifying optimal system architectures for a reference application are provided. The system and method comprise executing a reference application and a plurality of test applications on a current system architecture and sampling performance data for each of the applications. The performance data is used to compute an application signature for each application. A similarity element is derived from the application signatures that illustrates the similarity between each application and every other application. Using a similarity threshold and an algorithm, a subset of test applications that are similar to the reference application are derived.08-02-2012

Rosario Ciancimino, Berrien Springs, MI US

Patent application numberDescriptionPublished
20090109792SMOOTHING MOTOR SPEED DURING MIXING - A mixing system comprising a bowl, mixing element and motor. A mixing element is located within the bowl and is driven by a motor to impart mechanical energy to the foodstuff being mixed upon contact. A method for increasing the power to the motor comprises introducing additional current in advance of instantaneous loading.04-30-2009
20090110788UTILIZING MOTOR CURRENT VARIATIONS TO CONTROL MIXER OPERATION - A mixing system comprising a bowl, mixing element and motor. A mixing element is located within the bowl and is driven by a motor to impart mechanical energy to the foodstuff being mixed upon contact. A method for predicting instantaneous loading on the mixing system motor. A method for increasing the power to the motor comprises introducing additional current in advance of instantaneous loading. A method for identifying the foodstuff being mixed to control operation of the mixer either by allowing user interaction or increasing the current to the motor in advance of instantaneous loading and demands on the motor.04-30-2009
20100024662ROTATABLE WAFFLE MAKER - A waffle maker comprises a grill that is rotatable with respect to a base about a rotational axis.02-04-2010

Patent applications by Rosario Ciancimino, Berrien Springs, MI US

Rosario Drogo De Iacovo, Torino IT

Patent application numberDescriptionPublished
20090117925Method and System for Automatically Providing Contents From a Service Provider to a Mobile Telephonic Terminal - A method and a system are adapted to automatically provide contents, particularly multimedia contents, to mobile telephonic terminals of service subscribers; service subscription agreements information are stored in a repository of a service provider for each subscriber; and this information includes service conditions desired by each subscriber; such service conditions including specification of contents desired by each subscriber. Contents are provided to mobile telephonic terminals in push mode according to the conditions desired by each subscriber.05-07-2009

Rosario Iania, Torino IT

Patent application numberDescriptionPublished
20120261205MOTOR VEHICLE FRONT END - A motor vehicle front end has a frame, which supports a heat exchanger and has an upper horizontal crosspiece connected to two uprights by means of connection elements, which are plastically deformable so as to allow the upper horizontal crosspiece to be lowered in the event of an accident; the upper horizontal crosspiece comprises a rigid rear portion and a plastically deformable, front portion which is made of plastic material and is fixed to the rigid rear portion.10-18-2012

Rosario Lobrutto, Highland Mills, NY US

Patent application numberDescriptionPublished
20100247608PHARMACEUTICAL COMPOSITIONS COMPRISING HGH FOR ORAL DELIVERY - The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically active form, in particular after oral administration, as well as the use of oral dosage forms comprising human growth hormone and an absorption enhancer for the treatment of human growth hormone deficiencies and disorders associated therewith.09-30-2010

Rosario Machado Pinilla, Madrid ES

Patent application numberDescriptionPublished
20090202503SEQUENCE OF NUCLEOTIDES AND PEPTIDES GSE 24.2 OF DYSKERIN, WHICH CAN INDUCE TELOMERASE ACTIVITY, METHOD FOR OBTAINING SAME, THERAPEUTIC COMPOSITIONS AND APPLICATIONS THEREOF - This invention relates to a compound that induces or activates telomerase activity based on the nucleotide sequence of the GSE 24.2 fragment of dyskerin or the protein or peptide sequence encoded by said nucleotide sequence. Another part of the invention relates to vectors that comprise said sequence and cells transformed thereby, and pharmaceutical compositions that contain all these elements. These compositions may be used in the treatment of diseases from the following group: ageing or acceleration of ageing, neurodegenerative diseases and dyskeratosis congenita.08-13-2009
20110300115USE OF INDUCTOR AGENTS GSE24.2 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSES RELATING TO CELLULAR SENESCENCE - This invention describes the use of an inductor or activator compound GSE24.2 for producing a medicament or pharmaceutical composition for treating a preferably human illness or pathological situation caused by a senescence process. Said pharmaceutical composition can be useful for a treatment of tissue regeneration, for example of epithelial tissues or haematopoietic cells, and also for the immortalisation of eukaryote cells for use of same in biotechnological research or processes.12-08-2011

Rosario Monteriso, Trani IT

Patent application numberDescriptionPublished
20110223039PUMP ASSEMBLY AND METHOD - A pump assembly comprises a centrifugal pump configured to pump a multiphase fluid, a suction conduit in fluid communication with the centrifugal pump, and a discharge conduit in fluid communication with the centrifugal pump. The pump further comprises an eductor comprising one or more motive nozzles disposed within the suction conduit. Wherein the one or more motive nozzles are configured to introduce a motive fluid into the suction conduit and toward the centrifugal pump along a suction direction roughly co-directional with the suction conduit toward the centrifugal pump. A method and a pump assembly for pumping a multiphase fluid are also presented.09-15-2011

Rosario Nasto, Orbassano (torino) IT

Patent application numberDescriptionPublished
20130032106MULTI-CYLINDER INTERNAL COMBUSTION ENGINE WITH A SYSTEM FOR VARIABLE ACTUATION OF THE INTAKE VALVES SUBDIVIDED INTO SEPARATE SUB-UNITS - An engine comprises a system for variable actuation of the intake valves and is subdivided into a plurality of sub-systems independent with respect to each other, carried by a plurality of respective elements, each mounted on the cylinder head at a respective engine cylinder. Among other things, this considerably facilitates the system maintenance operations.02-07-2013
20130032107MULTI-CYLINDER INTERNAL COMBUSTION ENGINE WITH A SYSTEM FOR VARIABLE ACTUATION OF THE INTAKE VALVES AND AN INJECTOR HOUSING HAVING A RAISED SEALING EDGE - In a multi-cylinder internal combustion engine, provided with a system for variable actuation of the intake valves of the engine, the fuel injector associated to each engine cylinder is surrounded by a sealing casing which is part of a support body. The support body is mounted on the engine cylinder head with the interposition of a support surmounting the head and defining the seat in which the camshaft is received and it defines a sealing peripheral edge cooperating with a sealing cover which is mounted on the cylinder head. The cover has a general base plane sealingly mounted on the cylinder head or on the support. The sealing peripheral edge of each sealing casing is arranged in a parallel plane and raised with respect to the general base plane of the cover.02-07-2013

Rosario Nici, Monument, CO US

Patent application numberDescriptionPublished
20080272545Card Game - A card game is played between a dealer and at least one player. Each player is required to ante a bet before receiving a hand of cards. Cards are dealt to the dealer and each player so that the dealer and each player each receive two cards with faces of the dealer's cards hidden from each player. Each player is permitted to view their cards and the make additional bets. The cards dealt to the dealer are revealed. Each player holding a hand wherein the sum of the player's cards is within a selected amount of the sum of the dealer's cards is identified as a winner.11-06-2008
20080274791Card Game - A card game is played between a dealer and at least one player. Each player is required to ante a bet before receiving a hand of cards. Cards are dealt to the dealer and each player so that the dealer and each player each receive two cards with at least one of the faces of the dealer's cards hidden from each player. Each player is permitted to view their cards and the make additional bets. The hidden faces of the cards dealt to the dealer are revealed. Each player holding a hand wherein the sum of the player's cards is within a selected amount of the sum of the dealer's cards is identified as a winner.11-06-2008

Rosario Ocera, Rivoli(torino) IT

Patent application numberDescriptionPublished
20080217805Method and Apparatus for Producing a Seal Including a Portion Having a Wall of Variable Thickness - The method makes it possible to produce a seal (09-11-2008

Rosario Osta Pinzolas, Zaragoza ES

Patent application numberDescriptionPublished
20090226468Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS - The non-toxic proteolytic C fragment of tetanus toxin (TTC peptide) has the same ability to bind nerve cells and be retrogradely transported through a synapse as the native toxin. A hybrid protein encoded by the lacZ-TTC gene fusion retains the biological functions of both proteins in vivo, i.e. retrograde transynaptic transport of the TTC fragment and -gal enzymatic activity. After intramuscular injection, enzymatic activity could be detected in motoneurons and connected neurons of the brainstem areas. This strategy is useful for the delivery of a biological activity to neurons from the periphery to the central nervous system. Such a hybrid protein can also be used to map synaptic connections between neural cells.09-10-2009
20100239534Hybrid proteins that migrate retrogradely and transynaptically into the CNS - The non-toxic proteolytic C fragment of tetanus toxin (TTC peptide) has the same ability to bind nerve cells and be retrogradely transported through a synapse as the native toxin. A hybrid protein encoded by the IacZ-TTC gene fusion retains the biological functions of both proteins in vivo, i.e. retrograde transynaptic transport of the TTC fragment and β-gal enzymatic activity. After intramuscular injection, enzymatic activity could be detected in motoneurons and connected neurons of the brainstem areas. This strategy is useful for the delivery of a biological activity to neurons from the periphery to the central nervous system. Such a hybrid protein can also be used to map synaptic connections between neural cells.09-23-2010
20100261656Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin - The present invention relates to the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin and of the polypeptide encoded by said sequence, preferably for the treatment of amyotrophic lateral sclerosis (ALS).10-14-2010
20110002914HYBRID TETNUS TOXOID PROTEINS THAT MIGRATE RETROGRADELY AND TRANSYNAPTICALLY INTO THE CNS - The non-toxic proteolytic C fragment of tetanus toxin (TTC peptide) has the same ability to bind nerve cells and be retrogradely transported through a synapse as the native toxin. A hybrid protein encoded by the LacZ-TTC gene fusion retains the biological functions of both proteins in vivo, i.e. retrograde transynaptic transport of the TTC fragment and βgal enzymatic activity. After intramuscular injection, enzymatic activity can be detected in motoneurons and connected neurons of brainstem areas. This strategy is useful for the delivery of a biological activity to neurons from the periphery to the central nervous system. Such a hybrid protein can also be used to map synaptic connections between neural cells.01-06-2011

Patent applications by Rosario Osta Pinzolas, Zaragoza ES

Rosario Perona Abellon, Madrid ES

Patent application numberDescriptionPublished
20090202503SEQUENCE OF NUCLEOTIDES AND PEPTIDES GSE 24.2 OF DYSKERIN, WHICH CAN INDUCE TELOMERASE ACTIVITY, METHOD FOR OBTAINING SAME, THERAPEUTIC COMPOSITIONS AND APPLICATIONS THEREOF - This invention relates to a compound that induces or activates telomerase activity based on the nucleotide sequence of the GSE 24.2 fragment of dyskerin or the protein or peptide sequence encoded by said nucleotide sequence. Another part of the invention relates to vectors that comprise said sequence and cells transformed thereby, and pharmaceutical compositions that contain all these elements. These compositions may be used in the treatment of diseases from the following group: ageing or acceleration of ageing, neurodegenerative diseases and dyskeratosis congenita.08-13-2009
20110300115USE OF INDUCTOR AGENTS GSE24.2 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSES RELATING TO CELLULAR SENESCENCE - This invention describes the use of an inductor or activator compound GSE24.2 for producing a medicament or pharmaceutical composition for treating a preferably human illness or pathological situation caused by a senescence process. Said pharmaceutical composition can be useful for a treatment of tissue regeneration, for example of epithelial tissues or haematopoietic cells, and also for the immortalisation of eukaryote cells for use of same in biotechnological research or processes.12-08-2011

Rosario Ramon Albalate, Barcelona ES

Patent application numberDescriptionPublished
20100298538METHOD FOR THE STEREOSELECTIVE PREPARATION OF AMINO ACID DERIVATIVES - The invention relates to a process for the stereoselective preparation of amino acid derivatives, comprising a hydrogenation reaction of the compound of formula (III), alternatively its enantiomer, wherein R is (C11-25-2010

Rosario Rizzuto, Ferrara IT

Patent application numberDescriptionPublished
20100015603Chimeric proteins for measuring atp concentrations in pericellular space and related screening method - The invention relates to luminescent chimeric proteins comprising a first N-terminal protein sequence, a second protein sequence and a third C-terminal protein sequence wherein: 01-21-2010

Rosario Scollo, Misterbianco IT

Patent application numberDescriptionPublished
20100052559ELECTRONIC DRIVING DEVICE FOR LAMPS, IN PARTICULAR HID LAMPS - A driving device for a lamp, in particular an HID lamp, the device including a first circuit to convert a network input voltage into a output direct voltage, a second circuit that receives the direct voltage as an input and converts the direct voltage into an alternating signal for supplying the lamp. The first circuit includes a transformer provided with a secondary winding elements a center tap. The driving device further includes at least two capacitive elements connected to the center tap of the secondary winding of the transformer and coupled with the ends of the secondary winding and with the input of the second circuit.03-04-2010

Patent applications by Rosario Scollo, Misterbianco IT

Rosario Serrano Vargas, Navarra ES

Patent application numberDescriptionPublished
20100040596USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS - The present invention relates to the use of matrix metalloproteinase MMP-10 in the preparation of a pharmaceutical composition useful for thrombolytic therapy, it also being possible for said composition to contain a plasminogen activator. Additionally, the present invention relates to said pharmaceutical composition for the treatment of thrombotic disorders.02-18-2010
20110091436USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS - The present invention relates to the use of matrix metalloproteinase MMP-10 in the preparation of a pharmaceutical composition useful for thrombolytic therapy, it also being possible for said composition to contain a plasminogen activator. Additionally, the present invention relates to said pharmaceutical composition for the treatment of thrombotic disorders.04-21-2011

Rosario Serrano Vargas, Pamplona (navarra) ES

Patent application numberDescriptionPublished
20100135986COMPOSITIONS FOR ANTI-FIBRINOLYTIC TREATMENT - The present invention concerns the use of a neutralising antibody for matrix metalloproteinase-10 (MMP-10) in the preparation of a medicine useful for anti-fibrinolytic treatment, and for haemorrhages and haemorrhagic complications of various etiologies.06-03-2010

Rosario Stracquadaini, Vittoria IT

Patent application numberDescriptionPublished
20110149614DUAL MODE FLYBACK CONVERTER AND METHOD OF OPERATING IT - A DC-DC converter includes a power switching device and a mode control logic circuit to control the power switching device and generate an ON-pulse. A flip-flop is configured to be set by the mode control logic circuit. A current mode comparator is configured to reset the flip-flop and to compare a signal based upon current flowing through the power switching device with a signal based upon an output voltage of the dual mode flyback DC-DC converter. A transformer is driven by the current mode comparator. The mode control logic circuit includes a timer starting when a gate driver control signal applied to the power switching device turns the power switching device off and configured to generate a pulse when an off time interval elapses, a zero current detector circuit configured to sense a voltage on the transformer and generate a pulse when the voltage drops below a trigger threshold, and a combinatory logic circuit configured to compare pulse signals generated by the timer and the zero current detector circuit and generate the ON-pulse based thereupon.06-23-2011